ERCC1 intron 1 was associated with breast cancer risk

Archives of Medical Science

Volumn 8, Issue 4, 2012, Pages 655-658

  Mojgan, Hosseini ^a   Massoud, Houshmand ^b,c   Ahmad, Ebrahimi ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^c Special Medical Center Iran   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; ERCC1 gene; MboII; Polymerase chain reaction restriction fragment length polymorphism; Polymorphism; Susceptibility factor

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; INTRON; IRAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME;

EID: 84866857238     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.30289     Document Type: Article

References (22)

1. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1513-30. (Pubitemid 36020002)
2. Mousavi SM, Montazeri A, Mohagheghi MA, et al. Breast cancer in Iran: an epidemiological review. Breast J 2007; 13: 383-91. (Pubitemid 46985565)
3. Zhu Y, Spitz MR, Amos CI, Lin J, Schabath MB, Wu X. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res 2004; 64: 2251-7. (Pubitemid 38339480)
4. Wrensch M, Kelsey KT, Liu M, et al. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro-Oncology 2005; 7: 495-507. (Pubitemid 41555621)
5. Vogel U, Hedayati M, Dybdahl M, Grossman L, Nexo BA. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 2001; 22: 899-904. (Pubitemid 32514955)
6. Rieder MJ, Livingston RJ, Braun AC. Homo-sapiens excision repair cross-complementing deficiency, complementation group 1 (ERCC1) gene, and complete cds. (2002). NCBI (National Center for Bioinformatics). Accession #AF512555. (NIEHS-SNPs, Environmental Genome Project, NIEHS ES15478, Department of Genome Sciences, Seattle, Wash.) Available at http://www.ncbi.nlm.nih.gov/ entrez/viewer.fcgi?db=nucleotide&val=21105796.
7. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002; 12: 436-46. (Pubitemid 34233019)
8. Ronen A, Glickman BW. Human DNA repair genes. Environ Mol Mutagen 2001; 37: 241-83. (Pubitemid 32411130)
9. Zhu Y, Spitz MR, Amos CI, Lin J, Schabath MB, Wu X. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res 2004; 64: 2251-7. (Pubitemid 38339480)
10. Smith JS, Tachibana I, Pohl U, Lee HK. A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics 2006; 4: 44-50.
11. Aiub CA, Mazzei JL, Pinto LF, Felzenszwalb I. Participation of BER and NER pathways in the repair of DNA lesions induced at low N-nitrosodiethylamine concentrations. Toxicol Lett 2004; 154: 133-42. (Pubitemid 39314597)
12. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 2002; 17: 463-9. (Pubitemid 35414774)
13. Hou SM, Falt S, Angelini S, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002; 23: 599-603. (Pubitemid 34498497)
14. Sturgis EM, Zheng R, Li L, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000; 21: 2219-23. (Pubitemid 32049228)
15. Zhou W, Liu G, Miller DP, et al. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 2002; 62: 1377-81. (Pubitemid 34407795)
16. Zhou W, Liu G, Miller DP, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 359-65. (Pubitemid 36427997)
17. Hansen RD, Soørensen M, Tjoønneland A, Overvad K. A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study. BMC Cancer 2008; 8: 54.
18. Zhou W, Liu G, Park S, Wang Z, Wain JC. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 491-6. (Pubitemid 40270116)
19. Yu JJ, Mu C, Lee KB, et al. A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues. Mutat Res 1997; 382: 13-20. (Pubitemid 28376643)
20. Kim D, Jung W, Koo JS. The Expression of ERCC1, RRM1, and BRCA1 in Breast Cancer According to the Immunohistochemical Phenotypes. J Korean Med Sci 2011; 26: 352-9.
21. Schöffski P, Taron M, Jimeno J, Grosso F. Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study. Eur J Cancer 2011; 47: 1006-12.
22. Hosseini M, Houshmand M, Ebrahimi A. the ERCC2 K751 polymorphism is associated with breast cancer risk. Arch Med Sci 2009; 35: 455-9.